NAV
$55.50
AUM
$723.6M
Expense Ratio
-
Dividend Yield
3.41%
Beta
0.96
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +6.35% | +2.17% | +6.41% | +14.88% | +16.69% | +9.05% |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | ASML.AS | ASML Holding NV | 3.85% |
| 2 | HSBA.L | HSBC Holdings PLC | 1.98% |
| 3 | AZN.L | AstraZeneca PLC | 1.77% |
| 4 | NOVN.SW | Novartis AG Registered Shares | 1.76% |
| 5 | NESN.SW | Nestle SA | 1.61% |
| 6 | SHEL.L | Shell PLC | 1.46% |
| 7 | SIE.DE | Siemens AG | 1.45% |
| 8 | TTE.PA | TotalEnergies SE | 1.18% |
| 9 | SAP.DE | SAP SE | 1.14% |
Under normal market conditions, the fund generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. It employs a sampling strategy, which means that the fund is not required to purchase all of the securities represented in the index. The index is a free-float market capitalization weighted index designed to provide a broad representation of publicly traded Western European companies.
Inception Date: 2002-10-15